Brief: MiMedx Q4 Sales USD 86.832 Million Vs. IBES Estimate USD 85.1 Million
Feb 28 (Reuters) - MiMedx Q4 net income USD 53.476 million. * Q4 gross profit USD 72.991 million * Q4 operating income USD 15.489 million
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million